1073616-38-2

Upstream product

• 455-14-1 4-trifluoromethylphenylamine 
• 1073618-02-6 2-(5-chloro-6-(1,2,3,6-tetrahydropyridin-4-yl)pyridin-3-yl)propane-1,3-diol hydrochloride 
• 120800-05-7 2,3-dichloro-5-acetylpyridine 
• 41667-95-2 5,6-dichloronicotinic acid 
• 1073618-01-5 tert-butyl 4-(5-(1-tert-butyldimethylsilyloxy-3-hydroxypropan-2-yl)-3-chloropyridin-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 1073618-00-4 3-(tert-butyldimethylsilyloxy)-2-(5,6-dichloropyridin-3-yl)propan-1-ol 
• 1073617-99-8 5-(3-(tert-butyldimethylsilyloxy)prop-1-en-2-yl)-2,3-dichloropyridine 
• 1073617-98-7 2-(tert-butyldimethylsilyloxy)-1-(5,6-dichloropyridin-3-yl)ethanone 
• 1073617-83-0 (S)-1-(5,6-dichloropyridin-3-yl)ethane-1,2-diol 
• 1001193-62-9 2,3-dichloro-5-vinylpyridine 
• 54127-29-6 5,6-dichloronicotinoyl chloride 
• 54127-30-9 5,6-dichloro-3-pyridinemethanol 
• 71690-05-6 5,6-dichloro-pyridine-3-carbaldehyde 
• 162327-73-3 5,6-dichloro-N-methoxy-N-methyl-3-pyridinecarboxamide 

Relevant academic research and scientific papers

TRPV1 ANTAGONISTS AND USES THEREOF

The invention relates to compounds of formula (I) and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of formula I or a pharmaceutically acceptable derivative thereof.